A study of an MAb-GDNF fusion protein targeting the human insulin receptor failed to produce neuroprotection in an MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of PD in primates [126]. Here, GDNF is linked to Parkinson disease.